Essential ICD-10 Codes for Thyroid Nodules and Professional Coding Guidelines

Accurate medical coding for thyroid nodules is fundamental for clinical clarity, research, and ensuring appropriate insurance reimbursement. Within the ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification) framework, a thyroid nodule is not coded with a single "catch-all" identifier. Instead, the selection of the correct code depends on the functional status of the nodule, the number of nodules present, and the pathology results if a biopsy has been performed.

For those requiring a quick reference, the most frequently used ICD-10 codes for thyroid nodules include:

• E04.1: Nontoxic single thyroid nodule.
• E04.2: Nontoxic multinodular goiter.
• E05.10: Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm.
• D34: Benign neoplasm of the thyroid gland.
• C73: Malignant neoplasm of the thyroid gland.
• E04.9: Nontoxic goiter, unspecified.

Properly documenting these conditions requires a synthesis of physical examination findings, diagnostic imaging (primarily ultrasound), and laboratory results, specifically Thyroid Stimulating Hormone (TSH) levels.

Primary Classification of Nontoxic Thyroid Nodules

The majority of detected thyroid nodules are "nontoxic," meaning they do not produce excessive amounts of thyroid hormones (T3 and T4) and the patient remains euthyroid. These are primarily found in the E04 category.

What is the ICD 10 code for nontoxic single thyroid nodule?

The code E04.1 is the specific billable diagnosis code used for a solitary nontoxic thyroid nodule. It is also applicable to conditions described as a nontoxic uninodular goiter or a colloid nodule. This code is valid for the current fiscal year (including the updates for 2025 and 2026).

Clinical indicators for E04.1:

• Physical exam or ultrasound confirms only one discrete mass.
• TSH levels are within the reference range.
• The nodule is not producing symptoms of hyperthyroidism.

Coding for Nontoxic Multinodular Goiter

When a patient presents with multiple nodules, the diagnosis moves from uninodular to multinodular. The appropriate code is E04.2 (Nontoxic multinodular goiter). In clinical practice, this code is used even if the thyroid gland itself is not visibly enlarged but contains multiple distinct nodules identified via imaging.

It is important to note that E04.2 should be used rather than E04.1 if there are two or more nodules, as this reflects the complexity of the condition and the potential need for more intensive surveillance.

Coding for Functional or Toxic Thyroid Nodules

A "toxic" nodule is one that functions independently of the normal regulatory system, often leading to hyperthyroidism. This change in functional status shifts the coding from the E04 series (Nontoxic) to the E05 series (Thyrotoxicosis).

ICD 10 for Toxic Single Thyroid Nodule

If a single nodule is found to be "hot" or hyperfunctioning (typically confirmed via a radioactive iodine uptake scan), the correct code is E05.10 (Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm).

Key documentation requirements for E05.10:

• Suppressed TSH levels (usually < 0.1 mIU/L).
• Elevated Free T4 or T3 levels.
• Clinical symptoms of hyperthyroidism (tachycardia, weight loss, anxiety).

If the patient is experiencing a thyrotoxic crisis or "thyroid storm" alongside a toxic single nodule, the code escalates to E05.11.

Toxic Multinodular Goiter

In cases where multiple nodules are hyperfunctioning, the code E05.20 (Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm) is utilized. This distinguishes the condition from Graves' disease, which is an autoimmune cause of hyperthyroidism.

Distinguishing Between Benign and Malignant Neoplasms

While E04.1 and E04.2 describe the presence of nodules, they do not necessarily define the histopathological nature of the tissue. If a Fine Needle Aspiration (FNA) biopsy is performed, the coding may change based on the Bethesda classification or pathology report.

Benign Neoplasm of the Thyroid (D34)

The code D34 is used for a "Benign neoplasm of the thyroid gland." While many coders use E04.1 for a general benign nodule, D34 is more specific when a biopsy has confirmed a follicular adenoma or other benign neoplastic growth.

Expert Note: In many billing workflows, E04.1 is used for a "colloid nodule" (non-neoplastic), whereas D34 is reserved for "adenomas" (neoplastic). Using these correctly avoids clinical ambiguity in the patient's long-term record.

Malignant Neoplasm of the Thyroid (C73)

If the nodule is found to be cancerous (e.g., Papillary, Follicular, Medullary, or Anaplastic thyroid carcinoma), the diagnostic code must be updated to C73. This code is a high-level identifier that triggers different treatment pathways and significantly higher resource utilization in a hospital setting.

Neoplasm of Uncertain Behavior (D44.0)

In cases where the imaging or initial pathology is indeterminate (e.g., Bethesda III or IV), and the clinician is awaiting further molecular testing or surgical pathology, D44.0 (Neoplasm of uncertain behavior of thyroid gland) may be appropriate. However, most surveillance for "suspicious" nodules still defaults to E04.1 until malignancy is confirmed.

When to Use Unspecified Codes and Abnormal Findings

In the early stages of diagnosis, documentation might be sparse. However, over-reliance on unspecified codes can lead to insurance denials.

The Role of E04.9

E04.9 (Nontoxic goiter, unspecified) is often used when a clinician documents a "thyroid mass" or "thyroid lesion" without specifying if it is a single nodule or multinodular, and without confirming its functional status. While billable, this code lacks the specificity required for advanced clinical decision support and should be refined as soon as ultrasound or lab results are available.

Avoid Using R93.89 for Known Nodules

A common pitfall is coding an incidental finding of a thyroid nodule on a CT or MRI as R93.89 (Abnormal findings on diagnostic imaging of other specified body structures). Once a clinician confirms the finding is a thyroid nodule, the R-code (which is for symptoms or abnormal findings) should be replaced with a definitive diagnosis code from the E04 series.

Documentation Requirements for Accurate Coding

To support the medical necessity of thyroid ultrasounds, biopsies, and follow-up visits, the medical record must be precise. Professional coding experts suggest that providers include the following elements in their documentation:

1. Nodule Characteristics: Specify location (Right lobe, Left lobe, Isthmus), size (in centimeters), and composition (Solid, Cystic, Mixed).
2. Functional Status: Explicitly state "nontoxic" or "toxic" based on the TSH and Free T4 levels included in the chart.
3. Presence of Goiter: Document if the overall gland is enlarged or if the pathology is restricted to the nodule itself.
4. Clinical Symptoms: Note any compressive symptoms such as dysphagia (difficulty swallowing) or dyspnea (shortness of breath), which may justify surgical intervention.

Example of High-Quality Documentation

"Patient presents for follow-up of a 2.5 cm solid nodule in the right thyroid lobe. TSH is 1.2 mIU/L, indicating a nontoxic state. Ultrasound shows no suspicious microcalcifications. Diagnosis: Nontoxic single thyroid nodule (E04.1)."

Example of Poor Documentation

"Thyroid mass found on exam. Order ultrasound." (This results in the non-specific code E04.9 or potentially a denial due to lack of medical necessity).

Long-term Surveillance and Personal History

Thyroid nodules often require years of monitoring. Understanding how to code for follow-up encounters is vital for long-term patient management.

Coding for History of Thyroid Cancer

For patients who have had a thyroidectomy due to malignancy and are returning for surveillance to check for recurrence (which may appear as a "nodule" in the thyroid bed), the code Z85.850 (Personal history of malignant neoplasm of thyroid) should be used as a secondary code. This clarifies why an ultrasound is being performed in the absence of an intact thyroid gland.

Surveillance vs. Screening

It is crucial to differentiate between screening and surveillance.

• Z12.31 (Encounter for screening for malignant neoplasm of thyroid) is for asymptomatic patients with no known disease.
• Once a nodule is identified, the encounter is no longer screening; it is surveillance of a known condition, and the primary code should be the nodule itself (e.g., E04.1).

Impact on Reimbursement and MS-DRG

In an inpatient hospital setting, the ICD-10 code affects the Diagnosis-Related Group (DRG) assignment. For the 2025-2026 period, thyroid disorders generally map to MDC 10 (Endocrine, Nutritional & Metabolic Diseases).

• MS-DRG 643: Endocrine disorders with Major Complications or Comorbidities (MCC).
• MS-DRG 644: Endocrine disorders with Complications or Comorbidities (CC).
• MS-DRG 645: Endocrine disorders without CC/MCC.

Assigning a specific code like E05.10 (Toxic nodule) rather than E04.1 (Nontoxic) may accurately reflect a higher severity of illness due to the systemic effects of thyrotoxicosis, potentially impacting the relative weight of the case and subsequent reimbursement.

Common Coding Pitfalls to Avoid

• Confusing "Nodule" with "Goiter": A nodule is a discrete growth; a goiter is a general enlargement. Use E04.1 for a single nodule even if the term "goiter" is used in the notes, provided it is uninodular.
• Failure to Update After Biopsy: Many clinics keep a patient on E04.1 for years, even after a biopsy confirms a benign follicular adenoma. Updating to D34 provides better data quality for the healthcare system.
• Coding Symptoms Instead of the Diagnosis: If a nodule is confirmed, do not code "lump in neck" (R22.1). The specific thyroid code (E04.1) always takes precedence over a symptom code.

Summary of Key Thyroid Nodule Codes

Conclusion

Selecting the correct ICD-10 code for a thyroid nodule requires more than just identifying the presence of a mass. It demands an understanding of the patient's hormonal status and the physical distribution of the nodules. By consistently using specific codes like E04.1 for single nontoxic nodules and E05.10 for toxic ones, and by avoiding non-specific "R" codes, healthcare providers and coders can ensure accurate clinical records and minimize insurance claim denials. As clinical documentation standards evolve toward 2026, the emphasis remains on specificity: quantifying the nodules, confirming the TSH status, and integrating pathology results promptly into the coding workflow.

FAQ

What is the most common ICD-10 code for a thyroid nodule?

The most common code used is E04.1, which refers to a nontoxic single thyroid nodule. This is used for the majority of incidental findings on ultrasound where thyroid function is normal.

Can I use E04.1 for a thyroid cyst?

Yes, E04.1 includes "colloid nodule (cystic)" and "thyroid (cystic) nodule NOS." Unless the cyst is part of a multinodular goiter, E04.1 is the appropriate billable code.

How do I code a "hot" nodule found on a thyroid scan?

A "hot" nodule indicates hyperfunction. If the patient has associated thyrotoxicosis, you should use E05.10. If the patient is euthyroid despite the scan results (which is rare), you would consult the provider for clarification between E04.1 and E05.10.

Is E04.1 a chronic condition?

Yes, in many coding systems, E04.1 is flagged as a chronic condition, as thyroid nodules typically require long-term ultrasound surveillance to monitor for changes in size or appearance.

What is the difference between E04.1 and D34?

E04.1 is a general code for a nontoxic nodule or colloid cyst. D34 is a more specific code for a "benign neoplasm," such as a follicular adenoma. D34 is typically used only after a biopsy has confirmed the neoplastic nature of the nodule.